loadpatents
Patent applications and USPTO patent grants for Rao; Patricia E..The latest application filed is for "combination therapy of hsp90 inhibitors and pd-1 inhibitors for treating cancer".
Patent | Date |
---|---|
Combination Therapy Of Hsp90 Inhibitors And Pd-1 Inhibitors For Treating Cancer App 20180064689 - Proia; David A. ;   et al. | 2018-03-08 |
Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers Grant 8,815,945 - Nagai , et al. August 26, 2 | 2014-08-26 |
Use Of Bis [thiohydrazide Amide] Compounds Such As Elesclomol For Treating Cancers App 20130150440 - Nagai; Masazumi ;   et al. | 2013-06-13 |
Method of inhibiting stenosis and restenosis App 20050214299 - Horvath, Christopher J. ;   et al. | 2005-09-29 |
Method of inhibiting stenosis and restenosis Grant 6,663,863 - Horvath , et al. December 16, 2 | 2003-12-16 |
Method of inhibiting stenosis and restenosis App 20020106369 - Horvath, Christopher J. ;   et al. | 2002-08-08 |
Monoclonal antibody therapy Grant 4,731,244 - Talle , et al. March 15, 1 | 1988-03-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.